|
FASTKD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.9546002290366E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07869999990784E-07 |
| Normal-vs-Stage2 |
4.807600E-04 |
| Normal-vs-Stage3 |
8.30049995403925E-09 |
| Normal-vs-Stage4 |
4.92289986553374E-10 |
| Stage1-vs-Stage2 |
5.534600E-01 |
| Stage1-vs-Stage3 |
1.719970E-01 |
| Stage1-vs-Stage4 |
3.457800E-03 |
| Stage2-vs-Stage3 |
1.693010E-01 |
| Stage2-vs-Stage4 |
9.475600E-03 |
| Stage3-vs-Stage4 |
1.108960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77850001392699E-09 |
| Normal-vs-AfricanAmerican |
8.02959999601782E-08 |
| Normal-vs-Asian |
8.754200E-04 |
| Caucasian-vs-AfricanAmerican |
7.678500E-02 |
| Caucasian-vs-Asian |
3.066200E-01 |
| AfricanAmerican-vs-Asian |
6.186500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.45230000142749E-08 |
| Normal-vs-Female |
1.19989995717162E-09 |
| Male-vs-Female |
9.096000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.42559999974468E-07 |
| Normal-vs-Age(41-60Yrs) |
1.99450000959445E-09 |
| Normal-vs-Age(61-80Yrs) |
1.8082999997393E-07 |
| Normal-vs-Age(81-100Yrs) |
3.409400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.425800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.671200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.563590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.985800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.261600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.538630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.836500E-04 |
| Classical-VS-Follicular |
4.759200E-04 |
| Classical-VS-Other |
2.863200E-01 |
| Classical-VS-Normal |
3.51270001974768E-09 |
| Tall-VS-Follicular |
1.74359999771667E-08 |
| Tall-VS-Other |
5.899600E-02 |
| Tall-VS-Normal |
2.12174722236114E-12 |
| Follicular-VS-Other |
9.101800E-01 |
| Follicular-VS-Normal |
1.183640E-02 |
| Other-VS-Normal |
1.771570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.43269999980578E-07 |
| Normal-vs-N1 |
4.04989999980288E-07 |
| N0-vs-N1 |
1.196360E-01 |
|
|
